Interleukin23 in Systemic Lupus
Recruiting
N/A
Interventional Study
Systemic Lupus Erythematosus Related Interstial Lung Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 90 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
assement of interleukin 23 in serum of patients with systemic lupus erythematosus related interstial lung disease .
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with systemic lupus erythematous and patients with systemic lupus erythematosus with interstial lung disease.
Exclusion Criteria:
* patients with chest conditions rather than interstial lung disease \&who receiving biological blocking antibodies\& those treated with…
Contacts